AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol (August 7, 2002). doi:10.1152/ajpgi.00154.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/G1035    most recent
00154.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawakubo, K.
Right arrow Articles by Tache, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawakubo, K.
Right arrow Articles by Tache, Y.

Articles in PresS, published online ahead of print August 7, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00154.2002
Submitted on April 26, 2002
Accepted on July 25, 2002

Gastric protective effect of peripheral PYY through PYY preferring receptors in anesthetized rats

Keishi Kawakubo1, Hong Yang1, and Yvette Tache1*

1 Department of Medicine, Division of Digestive Diseases and Brain Research Institute, CURE:DDRC, UCLA, Los Angeles, CA, USA

* To whom correspondence should be addressed. E-mail: ytache{at}ucla.edu.

The influence of intravenous (iv) peptide YY (PYY) on the gastric injury induced by 45% ethanol was investigated in urethane-anesthetized rats. PYY (25, 75, 125 and 250 pmol/kg/h) significantly reduced gastric lesions by 36%, 59%, 40% and 38% respectively. Antibody against rat PYY injected iv (2 mg/kg) completely prevented the gastroprotective effect of iv PYY (75 pmol/kg/h), while injected intracisternally (ic, 460 µg/ 20 µl), it significantly prevented ic PYY (24 pmol/rat)-induced 58% reduction of ethanol lesions but not that induced by iv PYY. Vagotomy did not influence the gastroprotective effect of iv PYY. The Y1/"PYY-preferring" receptor agonist, [Pro34] PYY (75 pmol/kg/h, iv) significantly decreased ethanol-induced gastric lesions by 82%, while [Leu31, Pro34]NPY, a Y1/Y3 agonist, and PYY3-36, a Y2 agonist, had no effect. These data indicate that PYY infused iv at doses reported to mimic postprandial peak blood levels prevents ethanol-induced gastric injury through vagal independent pathways and PYY-preferring receptors.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1979 by the American Physiological Society.